0001104659-23-105910.txt : 20231002 0001104659-23-105910.hdr.sgml : 20231002 20231002162430 ACCESSION NUMBER: 0001104659-23-105910 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231001 FILED AS OF DATE: 20231002 DATE AS OF CHANGE: 20231002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fahey Sandell Jacquelyn CENTRAL INDEX KEY: 0001984647 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37625 FILM NUMBER: 231300015 MAIL ADDRESS: STREET 1: C/O VOYAGER THERAPEUTICS, INC. STREET 2: 64 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Voyager Therapeutics, Inc. CENTRAL INDEX KEY: 0001640266 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-5340 MAIL ADDRESS: STREET 1: 64 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 tm2327331-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-10-01 0 0001640266 Voyager Therapeutics, Inc. VYGR 0001984647 Fahey Sandell Jacquelyn C/O VOYAGER THERAPEUTICS, INC. 64 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Legal Officer 0 Common Stock 2023-10-01 4 A 0 61000 0 A 61000 D This equity award was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). Consists of shares of common stock underlying a restricted stock unit ("RSU") award. Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is October 1, 2023. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting upon the one-year anniversary of such vesting commencement date and the remainder vesting in equal annual installments thereafter, subject to the Reporting Person's continued service as an employee. /s/ Jacquelyn Fahey Sandell 2023-10-02